
Ozempic outperforms another diabetes drug for reducing stroke risk
Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared to patients taking another diabetes drug—empagliflozin. International researchers studied data from 7,899 patients treated with […]